BRAF/MEK inhibition induces cell state transitions boosting immune checkpoint sensitivity in BRAFV600E-mutant glioma.
Xing YL, Panovska D, Park JW, Grossauer S, Koeck K, Bui B, Nasajpour E, Nirschl JJ, Feng ZP, Cheung P, Habib P, Wei R, Wang J, Thomason W, Monje M, Xiu J, Beck A, Weber KJ, Harter PN, Lim M, Mahaney KB, Prolo LM, Grant GA, Ji X, Walsh KM, Mulcahy Levy JM, Hambardzumyan D, Petritsch CK.
Xing YL, et al.
Cell Rep Med. 2025 Jun 17;6(6):102183. doi: 10.1016/j.xcrm.2025.102183. Epub 2025 Jun 12.
Cell Rep Med. 2025.
PMID: 40505659
Free PMC article.